1.
Anatol J Cardiol
; 27(10): 608-610, 2023 09 30.
Article
En
| MEDLINE
| ID: mdl-37599635
Atrial Fibrillation , Cardiomyopathy, Hypertrophic , Thromboembolism , Humans , Atrial Fibrillation/complications , Atrial Fibrillation/drug therapy , Atrial Fibrillation/chemically induced , Thromboembolism/chemically induced , Anticoagulants/therapeutic use , Cardiomyopathy, Hypertrophic/complications , Cardiomyopathy, Hypertrophic/drug therapy , Risk Factors , Administration, Oral